Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD

Fig. 2

Serum concentrations of iFGF7 and iFGF23 in each CKD stage. Boxes represent the interquartile range with the upper and lower edges representing the 75th and 25th percentiles, respectively. The central horizontal lines represent the median serum concentrations. Only CKD4-5 demonstrate a statistically significant increase in serum iFGF23 concentrations relative to CKD1-3 (P < 0.01)

Back to article page